Table 1.
Reference | Study type | Country | Study period | Sample size (n) | Follow-up time (months) | |||
---|---|---|---|---|---|---|---|---|
Total | ART | SRT | ART | SRT | ||||
Briganti 2012 | match-controlled | Italy | 1991–2007 | 780 | 390 | 390 | Median (IQR):71.9 (39–103) | Median (IQR):41 (10–60) |
Buscariollo 2017 | retrospective cohort | United States | 1992–2013 | 401 | 171 | 230 | Median (IQR):89 (55–158) | Median (IQR):96 (63–130) |
Fossati 2016 | retrospective cohort | Italy | 1996–2009 | 510 | 243 | 267 | Median (IQR):94 (53–126) | Median (IQR):92 (70–136) |
Hwang 2018 | retrospective cohort | United States | 1987–2013 | 732 | 366 | 366 | Median (IQR):65.8 (40–107) | Median (IQR):73.3 (44.9–106.6) |
Borghetti 2017 | retrospective cohort | Italy | 1999–2012 | 258 | 127 | 131 | Overall median:50.7 | – |
Hervas 2017 | retrospective cohort | Spain | 1991–2011 | 702 | 223 | 479 | Overall median (range):34 (3–141) | – |
Mishra 2015 | retrospective cohort | United States | 1990–2009 | 186 | 74 | 112 | Overall median (range):103 (30–247) | – |
Hsu 2015 | retrospective cohort | United States | 1995–2009 | 305 | 76 | 229 | Overall median (range):74 (7–256) | – |
Tilki 2016 | retrospective cohort | Germany | 2005–2013 | 718 | 213 | 505 | Overall median (IQR):33.8 (17.1–49.0) | – |
Detti 2012 | retrospective cohort | Italy | 1995–2010 | 307 | 203 | 104 | Mean ± SD:3.3 ± 2.3 | Mean ± SD:4.5 ± 2.5 |
Ost 2011 | match-controlled | Belgium | 1999–2009 | 178 | 89 | 89 | Median (range):36 (3–120) | Median (range):36 (3–120) |
Trabulsi 2008 | matched-Control | United States | 1987–2002 | 192 | 96 | 96 | Median (range):97 (30–207) | Median (range):94 (26–190) |
Tsien 2003 | retrospective cohort | United States | 1986–1997 | 95 | 38 | 57 | Median (range):10.1 (4.8–14.5) | Median (range):8.8 (2.0–17.0) |
Taylor 2003 | retrospective cohort | United States | 1988–1998 | 146 | 75 | 71 | Median:68 | Median:39 |
ART: adjuvant radiotherapy; SRT: salvage radiotherapy; IQR: interquartile range; SD: standard deviation